| Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum. VPTS Marek Sochor, Petra Basova, Michal Pesta, Nina Dusilkova, Jiri Bartos ... BMC Cancer 14, 448, 2014 | 205* | 2014 |
| The role of PU. 1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesis P Burda, P Laslo, T Stopka Leukemia 24 (7), 1249-1257, 2010 | 205 | 2010 |
| MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia K Vargova, N Curik, P Burda, P Basova, V Kulvait, V Pospisil, F Savvulidi, ... Blood, The Journal of the American Society of Hematology 117 (14), 3816-3825, 2011 | 180 | 2011 |
| Expression patterns of microRNAs associated with CML phases and their disease related targets K Machová Poláková, T Lopotová, H Klamová, P Burda, M Trněný, ... Molecular cancer 10, 1-13, 2011 | 175 | 2011 |
| 5-azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU. 1 gene and cell differentiation capacity N Curik, P Burda, K Vargova, V Pospisil, M Belickova, P Vlckova, ... Leukemia 26 (8), 1804-1811, 2012 | 59 | 2012 |
| miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels K Musilova, J Devan, K Cerna, V Seda, G Pavlasova, S Sharma, J Oppelt, ... Blood, The Journal of the American Society of Hematology 132 (22), 2389-2400, 2018 | 50 | 2018 |
| PU.1 Activation Relieves GATA-1–Mediated Repression of Cebpa and Cbfb during Leukemia Differentiation P Burda, N Curik, J Kokavec, P Basova, D Mikulenkova, AI Skoultchi, ... Molecular Cancer Research 7 (10), 1693-1703, 2009 | 44 | 2009 |
| Aggressive acute myeloid leukemia in PU. 1/p53 double-mutant mice P Basova, V Pospisil, F Savvulidi, P Burda, K Vargova, L Stanek, ... Oncogene 33 (39), 4735-4745, 2014 | 43 | 2014 |
| BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia K Srutova, N Curik, P Burda, F Savvulidi, G Silvestri, R Trotta, H Klamova, ... Haematologica 103 (12), 2016, 2018 | 40 | 2018 |
| GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia. ST Burda P, Vargova J, Curik N, Salek C, Papadopoulos GL, Strouboulis J Plos One, 2016 | 29 | 2016 |
| Distinct and overlapping DNMT1 interactions with multiple transcription factors in erythroid cells: Evidence for co-repressor functions JS Dimitris N. Papageorgioua, Elena Karkouliaa, Alexandra Amaral-Psarrisa ... Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2016 | 11 | 2016 |
| Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous … N Curik, V Polivkova, P Burda, J Koblihova, A Laznicka, T Kalina, ... Frontiers in Oncology 11, 744373, 2021 | 6 | 2021 |
| Combined approach to leukemic differentiation using transcription factor PU. 1-enhancing agents P Bašová, H Paszeková, L Minařík, M Dluhošová, P Burda, T Stopka International Journal of Molecular Sciences 23 (12), 6729, 2022 | 4 | 2022 |
Tomáš Stopka MD, PhDAssociate ProfessorVerified email at lf1.cuni.cz
